ImmunityBio, Inc. SEC filings IBRX
ImmunityBio, Inc. has 554 filings in SEC EDGAR's recent list, going back to Apr 29, 2005. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 14, 2026 | Oct 14, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 6, 2026 | Oct 2, 2026 |
| 144 | Notice of proposed sale | Oct 5, 2026 | — |
| 144 | Notice of proposed sale | Oct 2, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 30, 2026 | Jul 29, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 2, 2026 |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 144 | Notice of proposed sale | Jul 2, 2026 | — |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 144 | Notice of proposed sale | Jul 1, 2026 | — |
| 144 | Notice of proposed sale | Jun 30, 2026 | — |
| 144 | Notice of proposed sale | Jun 29, 2026 | — |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 10, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 144 | Notice of proposed sale | Jun 4, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 18, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 9, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 9, 2026 | Apr 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 6, 2026 | Apr 6, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure, Other events
|
Mar 31, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 24, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 25, 2026 | — |
| 4 | Insider transaction | Feb 24, 2026 | Feb 23, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 22, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 22, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 22, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 22, 2026 |
| 4 | Insider transaction | Feb 24, 2026 | Feb 20, 2026 |
| 10-K | Annual report | Feb 23, 2026 | Dec 31, 2025 |
| 144 | Notice of proposed sale | Feb 23, 2026 | — |
| 8-K |
Current report
Results of operations
|
Feb 23, 2026 | Feb 23, 2026 |
| 8-K |
Current report
Other events
|
Feb 18, 2026 | Feb 18, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 10, 2026 |
| 8-K |
Current report
Material agreement
|
Jan 26, 2026 | Jan 23, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 21, 2026 | Jan 16, 2026 |
| 144 | Notice of proposed sale | Jan 20, 2026 | — |
| 144 | Notice of proposed sale | Jan 20, 2026 | — |
| 144 | Notice of proposed sale | Jan 16, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jan 15, 2026 | Jan 15, 2026 |
| 8-K |
Current report
Other events
|
Jan 14, 2026 | Jan 14, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 29, 2025 | Dec 23, 2025 |
| 424B5 | Prospectus supplement | Dec 29, 2025 | — |
| 4 | Insider transaction | Dec 16, 2025 | Dec 12, 2025 |
| 3 | Initial insider ownership | Dec 16, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 15, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Other events
|
Dec 12, 2025 | Dec 12, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 10, 2025 | — |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 4, 2025 |
| DEF 14C | Information statement | Oct 20, 2025 | Oct 20, 2025 |
| PRE 14C | Filing | Oct 8, 2025 | Oct 8, 2025 |
| 8-K |
Current report
Other events
|
Aug 8, 2025 | Aug 8, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 424B5 | Prospectus supplement | Jul 28, 2025 | — |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
|
Jul 25, 2025 | Jul 24, 2025 |
| S-8 | Employee stock plan registration | Jun 23, 2025 | — |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 20, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 20, 2025 | Jun 18, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Other events
|
May 5, 2025 | May 5, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 15, 2025 | Apr 15, 2025 |
| 424B5 | Prospectus supplement | Apr 8, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Apr 8, 2025 | Apr 7, 2025 |
| 8-K |
Current report
Auditor change
|
Mar 19, 2025 | Mar 13, 2025 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 22, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 22, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 22, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 22, 2025 |
| 4 | Insider transaction | Feb 25, 2025 | Feb 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2025 | Feb 7, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 12, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 7, 2025 | Feb 7, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 15, 2024 |
| 4 | Insider transaction | Dec 12, 2024 | Dec 10, 2024 |
| 424B5 | Prospectus supplement | Dec 12, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 11, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| 424B5 | Prospectus supplement | Dec 10, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 19, 2024 | Nov 19, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Material agreement
|
Jul 18, 2024 | Jul 13, 2024 |
| S-8 | Employee stock plan registration | Jun 20, 2024 | — |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2024 | Jun 11, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| EFFECT | Filing | May 2, 2024 | — |
| CORRESP | Letter to the SEC | Apr 30, 2024 | — |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 11, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 23, 2024 | Apr 22, 2024 |
| S-3ASR | Automatic shelf registration | Apr 17, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2024 | — |
| S-3 | Shelf registration | Mar 29, 2024 | — |
| CORRESP | Letter to the SEC | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 19, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 26, 2024 | Feb 22, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 26, 2024 | Feb 22, 2024 |
| 4 | Insider transaction | Feb 6, 2024 | Feb 5, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Jan 31, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Jan 4, 2024 | — |
| 4 | Insider transaction | Jan 3, 2024 | Dec 29, 2023 |
| 4 | Insider transaction | Jan 3, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Jan 3, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Jan 2, 2024 | Dec 29, 2023 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 15, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| DEF 14C | Information statement | Sep 28, 2023 | Sep 28, 2023 |
| D | Filing | Sep 22, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Sep 21, 2023 | — |
| PRE 14C | Filing | Sep 18, 2023 | Sep 15, 2023 |
| 4 | Insider transaction | Sep 13, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Sep 11, 2023 | Sep 11, 2023 |
| 4 | Insider transaction | Sep 6, 2023 | Sep 1, 2023 |
| 4 | Insider transaction | Sep 6, 2023 | Sep 1, 2023 |
| 4 | Insider transaction | Sep 6, 2023 | Sep 1, 2023 |
| 8-K |
Current report
Other events
|
Sep 1, 2023 | Aug 31, 2023 |
| 4 | Insider transaction | Aug 28, 2023 | Aug 25, 2023 |
| 4 | Insider transaction | Aug 28, 2023 | Aug 25, 2023 |
| 4 | Insider transaction | Aug 28, 2023 | Aug 25, 2023 |
| 8-K |
Current report
Other events
|
Aug 15, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 424B5 | Prospectus supplement | Jul 25, 2023 | — |
| 424B5 | Prospectus supplement | Jul 24, 2023 | — |
| 8-K |
Current report
Material agreement
|
Jul 21, 2023 | Jul 20, 2023 |
| 8-K |
Current report
Other events
|
Jul 20, 2023 | Jul 20, 2023 |
| 4 | Insider transaction | Jun 16, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 15, 2023 | Jun 13, 2023 |
| 4 | Insider transaction | Jun 15, 2023 | Jun 13, 2023 |
| 4 | Insider transaction | Jun 15, 2023 | Jun 13, 2023 |
| 4 | Insider transaction | Jun 15, 2023 | Jun 13, 2023 |
| 4 | Insider transaction | Jun 15, 2023 | Jun 13, 2023 |
| 4 | Insider transaction | Jun 15, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Material agreement, New debt, Shareholder vote results
|
Jun 14, 2023 | Jun 13, 2023 |
| 4 | Insider transaction | Jun 5, 2023 | Jun 5, 2023 |
| 4 | Insider transaction | Jun 5, 2023 | Jun 2, 2023 |
| 4 | Insider transaction | Jun 5, 2023 | Jun 1, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | May 23, 2023 | — |
| 4 | Insider transaction | May 16, 2023 | May 12, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Other events
|
May 11, 2023 | May 9, 2023 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 31, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Other events
|
Mar 20, 2023 | Mar 20, 2023 |
| 3/A | Form 3/a | Mar 1, 2023 | Mar 9, 2021 |
| 10-K | Annual report | Mar 1, 2023 | Dec 31, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IBRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1326110
- Former names
- NantKwest, Inc. (until Mar 8, 2021); Conkwest, Inc. (until Jul 13, 2015); ZelleRx Corp (until Oct 9, 2009)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.